Onsolis is a prescription medication that is used to manage breakthrough cancer pain in patients who are already receiving around-the-clock opioid therapy for their underlying persistent cancer pain. This medication comes in the form of a buccal film that is placed inside the cheek, where it quickly dissolves and delivers the active ingredient, fentanyl, into the bloodstream.

Fentanyl is a potent opioid that works by binding to specific receptors in the brain and spinal cord to reduce the perception of pain. Onsolis is designed to provide rapid relief from breakthrough pain, which is sudden and intense pain that can occur despite the use of around-the-clock pain medication.

It is important to follow the dosing instructions provided by your healthcare provider when using Onsolis. The medication should not be used more frequently than every four hours, and the dose should be adjusted based on the individual’s response to the medication.

As with any medication, there are potential side effects associated with Onsolis. These may include nausea, vomiting, constipation, dizziness, and drowsiness. It is important to discuss any concerns or side effects with your healthcare provider.

Onsolis should only be used under the supervision of a healthcare provider experienced in the use of potent opioids for the management of pain. It is important to store this medication securely and out of reach of children or others who may misuse it.

If you have any questions about Onsolis or its use in managing breakthrough cancer pain, please consult with your healthcare provider for more information.